ESTROPUR
Composition - 1 ml:
Cloprostenolum natricum - 75 µg, chlorocresol, citrate of sodium, citric acid, water for injections.
Effect method:
Cloprostenol sodium salt, a functional F2-alpha prostaglandin analogue, is distinguished by a specific luteolytic effect. The corpus luteum extinction creates conditions for rutting and ovulation. The period from the preparation administration to the first symptoms of oestrus is 48 - 60 hrs, the best time for insemination is about the 76th hour after administration.
Indication:
BiotechnicalOestrum provocation and synchronizing in heifers and cows, synchronizing of sexual cycle of donors and recipients in the programme of bovine early embryos transfer, induction of farrow in sows.
Therapeutic
Cattle:
Indication group:
Veterinary pharmaceutical preparation - luteolytic
Contraindication:
The ingestion in the course of planned and physiologically normal pregnancy, when the interruption is not requested from the therapeutic point of view.
Interaction:
Unknown
Method of administration:
Intramuscularly
Method of administration and dosage:
Cattle:
Adverse effects:
Unknown
Package Availability:
10 x 2 ml, 10 x 4 ml, 1 x 10 ml, 5 x 10 ml, 5 x 20 ml
Warning:
Pregnant women should avoid handling this preparation.
Storage:
Store in a dry place at the temperature of 10 to 25 oC. Protect from light!
To be consumed within 14 days after the 1st opening. Do not use after the expiry date stated on the label.
Protection period:
Cloprostenolum natricum - 75 µg, chlorocresol, citrate of sodium, citric acid, water for injections.
Effect method:
Cloprostenol sodium salt, a functional F2-alpha prostaglandin analogue, is distinguished by a specific luteolytic effect. The corpus luteum extinction creates conditions for rutting and ovulation. The period from the preparation administration to the first symptoms of oestrus is 48 - 60 hrs, the best time for insemination is about the 76th hour after administration.
Indication:
BiotechnicalOestrum provocation and synchronizing in heifers and cows, synchronizing of sexual cycle of donors and recipients in the programme of bovine early embryos transfer, induction of farrow in sows.
Therapeutic
Cattle:
- functional disorders of ovaries, postpartal and postservice anestrus (silent oestrus, irregular and anovulatory cycle, persisting corpus luteum, luteal cyst).
- Postpuerperal uterus disorders, endometritis, pyometritis. Normal and pathological pregnancy interruption (in the first half of gestation).
- Combined therapy of follicular cysts (10th to 14th day after LHRH administration, when positive ovarian response is detected).
Indication group:
Veterinary pharmaceutical preparation - luteolytic
Contraindication:
The ingestion in the course of planned and physiologically normal pregnancy, when the interruption is not requested from the therapeutic point of view.
Interaction:
Unknown
Method of administration:
Intramuscularly
Method of administration and dosage:
Cattle:
- oestrum synchronizing - 2 ml of the preparation (0.15 mg of active substance). When oestrum synchronizing, first determine the corpus luteum (6th to 18th day of the cycle) and based on the developing oestrum symptoms, inseminate 70 to 120 hours after administration. If oestrum does not develop, the preparation may be administered again on the 11th day after the first treatment. In embryo donors, administer the 3rd day after the superovulation preparation start (morning dose 2 ml, evening dose 2 ml). When treating functional ovary disorders, inseminate at the first oestrum provoked by the preparation administration; if oestrum does not appear, it is possible to repeat the administration on the 11th day. At combined therapy of follicular cysts, administrate ESTROPUR inj. on the 10th to 14th day after LHRH administration (Dirigestran inj., Supergestran inj.) based on positive ovarian response detection. When treating postpuerperal diseases of uterus, repeat the administration at intervals of 10 days, inseminate solely after the second administration.
- administer (behind the ear) a one-shot dose of 1 ml of preparation (75 µg of active substance) from the 111th day of pregnancy. Most induced farrowings start between the 19th and 30th hour after administration.
Adverse effects:
Unknown
Package Availability:
10 x 2 ml, 10 x 4 ml, 1 x 10 ml, 5 x 10 ml, 5 x 20 ml
Warning:
Pregnant women should avoid handling this preparation.
Storage:
Store in a dry place at the temperature of 10 to 25 oC. Protect from light!
To be consumed within 14 days after the 1st opening. Do not use after the expiry date stated on the label.
Protection period:
- Meat: 24 hours
- Milk: 4 hours
